Targetable molecular algorithm and training platform development for the treatment of non-small cell lung cancer.

ABSTRACT:

Background and introduction

Over the last decade, treatment of patients with advanced non-small cell lung cancer (NSCLC) has become dependent on tissue and/or blood biomarkers to guide treatment decisions. Timely access to comprehensive biomarker and tumor signature information is crucial for diagnostic testing. With the rapid development and implementation of complex biomarker testing, comprehensive molecular profiling with in-depth analysis of DNA, RNA, and proteins can be easily performed. Initial data from the MedStar Health system showed considerable disparities in the use of next generation sequencing (NGS) between hospitals, and there is a clear need to improve education and understanding regarding which cases are appropriate for NGS, as well as the use of protocols to make

SUBMITTER: Bhuvaneshwar K 

PROVIDER: S-EPMC11540162 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature